STEP vs WST · rev $1.99B vs P/E 35, rev $2.89B
Stepstone Group Inc (STEP) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Stepstone Group Inc (STEP) is a asset management company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported STEP revenue for 2026-03-31 was $1.99B. Net income was -$535.8M. Revenue was up 69.7% from 2025-03-31 to 2026-03-31. STEP currently screens at market cap $5.78B.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
STEP currently screens at market cap $5.78B. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the STEP and WST stock pages for the full models.
Not investment advice.